Data spanning the past 90 days through December 17, 2025 reveals that Outlook Therapeutics's three principal insider shareholders consist of Director Ghiath M. Sukhtian (13.55Mn shares), Chief Commercial Officer Jeff Evanson (40.42K shares), Chief Operations Officer Terry Dagnon (32.65K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Faisal Ghiath Sukhtian | 2,794,239 | 11 Oct, 2022 | |
| Arun Kumar Pillai | 1,149,126 | 01 Feb, 2022 | |
| Pte Ltd. Biolexis | 1,149,126 | 22 Apr, 2022 | |
| Ghiath M. Sukhtian | 13,552,359 | 28 May, 2025 | |
| Ventures Llc Syntone | 1,705,438 | 17 Apr, 2024 | |
| Jeff Evanson | Chief Commercial Officer | 40,423 | 11 Mar, 2024 |
| Terry Dagnon | Chief Operations Officer | 32,653 | 21 Apr, 2023 |
| Kurt J Hilzinger | 23,656 | 05 Oct, 2022 | |
| C Russell Iii Trenary | CEO And President | 2,746 | 23 Jun, 2022 |
| Lawrence A Kenyon | Chief Financial Officer | 5,946 | 30 Sep, 2024 |
| Yezan Munther Haddadin | 5,049 | 29 Mar, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 27 May, 2025 | Ghiath M. Sukhtian | Common Stock | A | 4,285,714 | $1.40 | 13,552,359 | I | A |
| 17 Jan, 2025 | Ghiath M. Sukhtian | Common Stock | A | 3,458,571 | $2.51 | 9,266,645 | I | M |
| 26 Sep, 2024 | Lawrence A Kenyon | Common Stock | A | 5,000 | $5.69 | 5,946 | D | P |
| 26 Sep, 2024 | Lawrence A Kenyon | - | - | 5,946 | D | |||
| 15 Apr, 2024 | Ventures Llc Syntone | Common Stock | A | 714,286 | - | 1,705,438 | D | P |
| 15 Apr, 2024 | Ventures Llc Syntone | - | - | 1,705,438 | D | |||
| 28 Mar, 2024 | Yezan Munther Haddadin | - | - | 5,049 | D | |||
| 28 Mar, 2024 | Yezan Munther Haddadin | Common Stock | A | 1,882 | $11.82 | 5,049 | D | P |
| 18 Mar, 2024 | Ghiath M. Sukhtian | Common Stock | A | 2,305,714 | - | 5,808,074 | I | A |
| 18 Mar, 2024 | Ghiath M. Sukhtian | - | - | 5,808,074 | I | |||
| 07 Mar, 2024 | Jeff Evanson | - | - | 40,423 | D | |||
| 07 Mar, 2024 | Jeff Evanson | Common Stock | A | 62,484 | $0.42 | 40,423 | D | P |
| 20 Apr, 2023 | Terry Dagnon | - | - | 32,653 | D | |||
| 20 Apr, 2023 | Terry Dagnon | Common Stock | D | 520,000 | $1.14 | 32,653 | D | S |
| 20 Jan, 2023 | Jeff Evanson | Common Stock | D | 267,000 | $1.11 | 37,299 | D | S |
| 17 Jan, 2023 | Jeff Evanson | Common Stock | D | 27,162 | $1.31 | 57,498 | D | S |
| 17 Jan, 2023 | Jeff Evanson | - | - | 57,498 | D | |||
| 18 Jan, 2023 | Jeff Evanson | - | - | 55,812 | D | |||
| 18 Jan, 2023 | Jeff Evanson | Common Stock | D | 33,738 | $1.25 | 55,812 | D | S |
| 19 Jan, 2023 | Jeff Evanson | - | - | 50,649 | D |